Brought to you by:
CX Aortic Vienna: Cardiac, vascular surgeons collaborate at the vanguard of aortic care
CX Aortic Vienna returns in October for its third edition (Oct. 24–26, Digital), bringing together world-leading specialists from the cardiac and vascular fields to discuss all facets of aortic care from selection to investigation, diagnosis, techniques and technologies. The meeting…
Innovation within the Veterans Health Administration
If one were to ask the average citizen where cutting-edge technology is developed, the most probable answer would be “private industry”; think Apple, Tesla, Uber. This lies in the belief that the U.S. government is slow, risk-averse and cumbersome when…
AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system
AngioDynamics recently announced receiving Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system to include arterial thrombectomy. The FDA recently cleared the expanded indication for the Auryon system’s 2mm and 2.35mm catheters to include adjacent…
Vascular experts establish appropriate use of IVUS in peripheral interventions
Royal Philips today announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease: the establishment of the first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in lower-extremity arterial and venous interventions. Published…
Patient-reported outcomes in vascular surgery are here to stay
In 2022, the Centers for Medicare and Medicaid Services (CMS) is again emphasizing the importance of patient-reported outcomes (PROs) through legislation regarding the Quality Payment Program. In the Merit-based Incentive Payment System (MIPS), the use of PRO tools was designated…
Selution SLR receives second FDA IDE approval
Selution SLR, MedAlliance’s sirolimus-eluting balloon, has received conditional Food and Drug Administration (FDA) investigational device exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial femoral artery (SFA). This comes only a…
CLTI: Translating guidelines into practice
Clinical practice guidelines (CPG) are integral to helping achieve optimal patient care. The Society for Vascular Surgery (SVS) clinical guidelines are evidence-based and the recommendations assist physicians in clinical decision-making in their daily practices. The challenge for practicing physicians “is…
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease who utilise graft circuits for dialysis treatment. Jeffrey Lawson, MD, PhD, and Shawn Gage, PA-C, of…
JACC study makes case for expanding coverage for carotid artery stenting
Research from Ochsner Health published in the Journal of the American College of Cardiology (JACC) is likely to influence expanded insurance coverage for carotid artery stenting. The paper, “Carotid artery stenting: JACC state-of-the art review”, details significant advances in the field of…
Compression duration affects pain during superficial venous intervention, study finds
Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This is according to a study published in the August edition of the British Journal of Surgery…